Most of the focus has been placed on the role of IKKβ in canonical NFκB pathway, which triggers an innate immunity response that determines the extent of damage at the early phase of AKI (Ghosh and Karin, 2002; Wan et al., 2011). The gene discussed is NFKB1; the disease is acute kidney injury.